0.00Open0.00Pre Close0 Volume0 Open Interest2.00Strike Price0.00Turnover0.00%IV493.47%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.74Leverage Ratio--Theta--Rho--Eff Leverage--Vega
萬軍無兵策天鳳 : Without the start of sales and good sales data, it feels difficult to drive the stock price.
Trytosaveabit OP 萬軍無兵策天鳳 : Agreed! Hehehe! I do hate when companies release what could be great news and don’t put the important parts! Like a contract! But not how much it’s worth? Hehehe GL
一哭二闹三上悠亚 萬軍無兵策天鳳 : Since 2020, the current stocks are still down by 70%, so new investors should not hold large positions. After FDA approval in 90 days, there was a sharp drop on the same day, followed by a sustained decline for six months. Recently, after FDA approval in 365 days, the stocks dropped back to near the lowest point within two days. Every financial report results in explosions, CEOs frequently sell stocks, split shares, and issue new shares that are not beneficial to shareholders. Moreover, the company's products are all prescription drugs with limited sales channels and the company is heavily indebted, so it would not be surprising if it goes bankrupt one day.